SEC Filing Document

Company: DUKE Robotics Corp.
Ticker: DUKR
CIK: 1638911
Filing Type: S-1/A
Document Type: EX-1.1
Date Filed: 2026-04-27
Accession Number: 0001213900-26-048102
Exchange: OTC
SIC Code: 3721
SIC Description: Aircraft
URL: https://www.sec.gov/Archives/edgar/data/1638911/000121390026048102/ea028763601ex1-1.htm

Chunk 4 of 21
Word Count: 1385
Character Count: 8793

Document Content:

the part of the Company and no further action is required by the Company, the Board of Directors or the Company’s stockholders in connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which the Company is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.

(d)	No Conflicts.
The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party, the
issuance and sale of the Securities and the Representative’s Securities and the consummation by it of the transactions contemplated
hereby and thereby do not and will not (i) conflict with or violate any provision of the Company’s or any Subsidiary’s certificate
or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or
an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties
or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, acceleration or cancellation (with
or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary
debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company
or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law,
rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company
or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company
or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and	such as could not have or reasonably be expected
to result in a Material Adverse Effect.

(e) Filings,
Consents and Approvals. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to,
or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection
with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filing with the Commission
of the Prospectus, (ii) such filings as are required to be made under applicable state securities laws and (iii) application(s) to each
applicable Trading Market for the listing of the Shares, the Warrant Shares and the shares of Common Stock issuable upon exercise of the
Representative’s Warrant for trading thereon in the time and manner required thereby (collectively, the “Required Approvals”).

(f) Registration
Statement. The Company has filed with the Commission the Registration Statement, including any related Preliminary Prospectus or Prospectuses,
for the registration of the Securities under the Securities Act, which Registration Statement has been prepared by the Company in conformity
with the requirements of the Securities Act and the rules and regulations of the Commission under the Securities Act. The registration
of the Common Stock under the Exchange Act has been declared effective by the Commission on or prior to and is effective on the date hereof
Copies of such Registration Statement and of each amendment thereto, if any, including the related Preliminary Prospectuses, heretofore
filed by the Company with the Commission have been delivered to the Underwriters. The term “Registration Statement”
means such registration statement on Form S-1 (File No. 333-294808), as amended, as of the relevant Effective Date, including financial
statements, all exhibits and any information deemed to be included or incorporated by reference therein, including any information deemed
to be included pursuant to Rule 430A or Rule 430B of the Securities Act and the rules and regulations thereunder, as applicable. If the
Company files a registration statement to register a portion of the Securities and relies on Rule 462(b) of the Securities Act and the
rules and regulations thereunder for such registration statement to become effective upon filing with the Commission (the “Rule
462 Registration Statement”) then any reference to the “Registration Statement” shall be deemed to include
the Rule 462 Registration Statement, as amended from time to time. The term “Preliminary Prospectus” as used herein
means a preliminary prospectus as contemplated by Rule 430 or Rule 430A of the Securities Act and the rules and regulations thereunder
as included at any time as part of, or deemed to be part of or included in, the Registration Statement. The term “Prospectus”
means the final prospectus in connection with this Offering as first filed with the Commission pursuant to Rule 424(b) of the Securities
Act and the rules and regulations thereunder or, if no such filing is required, the form of final prospectus included in the Registration
Statement at the Effective Date, except that if any revised prospectus or prospectus supplement shall be provided to the Representative
by the Company for use in connection with the Securities which differs from the Prospectus (whether or not such revised prospectus or
prospectus supplement is required to be filed by the Company pursuant to Rule 424(b)), the term “Prospectus” shall
also refer to such revised prospectus or prospectus supplement, as the case may be, from and after the time it is first provided to the
Representative for such use. Any reference herein to the terms “amend”, “amendment” or “supplement”
with respect to the Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include: (i)
the filing of any document under the Exchange Act after the Effective Date, the date of such Preliminary Prospectus or the date of the
Prospectus, as the case may be, which is incorporated therein by reference, and (ii) any such document so filed. All references in this
Agreement to the Registration Statement, a Preliminary Prospectus and the Prospectus, or any amendments or supplements to any of the foregoing
shall be deemed to include any copy thereof filed with the Commission pursuant to its Electronic Data Gathering, Analysis and Retrieval
System (“EDGAR”). The term “General Disclosure Package” means, collectively, the Permitted Free
Writing Prospectus(es) (as defined below) issued at or prior to the date hereof, the most recent preliminary prospectus related to this
offering, and the information included on Schedule I hereto.

(g) Issuance
of Securities. The Public Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction
Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Warrant
Shares are duly authorized and, when issued in accordance with the terms of the Warrants, will be validly issued, fully paid and nonassessable,
free and clear of all Liens imposed by the Company. The Representative’s Securities are duly authorized and, when issued and paid
for in accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear
of all Liens imposed by the Company. The Company has reserved from its duly authorized capital stock the maximum number of shares of Common
Stock issuable pursuant to this Agreement, the Warrants and the Representative’s Warrants. None of the Securities are or will be
subject to the preemptive rights of any holders of any security of the Company or similar contractual rights granted by the Company. All
corporate action required to be taken for the authorization, issuance and sale of the Securities has been duly and validly taken. The
Securities conform in all material respects to all statements with respect thereto contained in the Registration Statement, the General
Disclosure Package and the Prospectus.